184 related articles for article (PubMed ID: 16679074)
21. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
Ai M; Heeger S; Bartels CF; Schelling DK;
Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
[TBL] [Abstract][Full Text] [Related]
22. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
Rickels MR; Zhang X; Mumm S; Whyte MP
J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
[TBL] [Abstract][Full Text] [Related]
23. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
24. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
Agueda L; Bustamante M; Jurado S; Garcia-Giralt N; Ciria M; Saló G; Carreras R; Nogués X; Mellibovsky L; Díez-Pérez A; Grinberg D; Balcells S
J Bone Miner Res; 2008 Dec; 23(12):1954-63. PubMed ID: 18684085
[TBL] [Abstract][Full Text] [Related]
25. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.
Downey LM; Bottomley HM; Sheridan E; Ahmed M; Gilmour DF; Inglehearn CF; Reddy A; Agrawal A; Bradbury J; Toomes C
Br J Ophthalmol; 2006 Sep; 90(9):1163-7. PubMed ID: 16929062
[TBL] [Abstract][Full Text] [Related]
26. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
27. Influence of LRP5 polymorphisms on normal variation in BMD.
Koay MA; Woon PY; Zhang Y; Miles LJ; Duncan EL; Ralston SH; Compston JE; Cooper C; Keen R; Langdahl BL; MacLelland A; O'Riordan J; Pols HA; Reid DM; Uitterlinden AG; Wass JA; Brown MA
J Bone Miner Res; 2004 Oct; 19(10):1619-27. PubMed ID: 15355556
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of Lrp5 function in osteoblast progenitors.
Yadav VK; Arantes HP; Barros ER; Lazaretti-Castro M; Ducy P
Calcif Tissue Int; 2010 May; 86(5):382-8. PubMed ID: 20333369
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome.
Barros ER; Dias da Silva MR; Kunii IS; Hauache OM; Lazaretti-Castro M
Osteoporos Int; 2007 Jul; 18(7):1017-8. PubMed ID: 17437160
[No Abstract] [Full Text] [Related]
30. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
31. An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components.
Springer TA
J Mol Biol; 1998 Nov; 283(4):837-62. PubMed ID: 9790844
[TBL] [Abstract][Full Text] [Related]
32. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women.
Bollerslev J; Wilson SG; Dick IM; Islam FM; Ueland T; Palmer L; Devine A; Prince RL
Bone; 2005 Apr; 36(4):599-606. PubMed ID: 15777745
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.
Biha N; Ghaber SM; Hacen MM; Collet C
Case Rep Genet; 2016; 2016():9814928. PubMed ID: 26904320
[TBL] [Abstract][Full Text] [Related]
34. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
[TBL] [Abstract][Full Text] [Related]
35. Potential blindness in children of patients with hereditary bone disease.
Kheir V; Munier FL; Aubry-Rozier B; Schorderet DF
Osteoporos Int; 2016 Feb; 27(2):841-4. PubMed ID: 26243358
[TBL] [Abstract][Full Text] [Related]
36. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
Balemans W; Van Hul W
Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
[TBL] [Abstract][Full Text] [Related]
37. Familial exudative vitreoretinopathy and osteoporosis-pseudoglioma syndrome caused by a mutation in the LRP5 gene.
Drenser KA; Trese MT
Arch Ophthalmol; 2007 Mar; 125(3):431-2. PubMed ID: 17353424
[No Abstract] [Full Text] [Related]
38. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
39. Two novel mutations 685del 1 and D129G in the low-density lipoprotein receptor gene in a compound heterozygote Chinese family with familial hypercholesterolemia.
Chen K; Mu YM; Wang BA; Guo QH; Lu ZH; Dou JT; Lu JM
Metabolism; 2007 May; 56(5):636-40. PubMed ID: 17445538
[TBL] [Abstract][Full Text] [Related]
40. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
